Ulcerative colitis

March 2, 2016March 2, 2016

Gut Microbiome in IBD Patients Responds Differently to Iron Supplements Given Oral and Intravenously

Crohn's Disease, IBD News, News, Ulcerative colitis

Researchers from the Technical University of Munich, Germany, found that iron supplementation in patients with inflammatory bowel disease (IBD) affects the gut microbiome differently, depending on the route of administration. Intravenous ... Read more

February 25, 2016May 17, 2016

Possible Treatment for Ulcerative Colitis: Common Vinegar

IBD News, News, Ulcerative colitis

New research has investigated the therapeutic power of vinegar – a common ingredient in the Mediterranean diet – in the fight against ulcerative colitis (UC), an inflammatory bowel disease (IBD) that researchers think ... Read more

February 17, 2016February 17, 2016

Children with Ulcerative Colitis May Be Safely Treated with Multimatrix Mesalamine

IBD News, News, Ulcerative colitis

A study from the Johns Hopkins University School of Medicine reported that children and adolescents with ulcerative colitis (UC) reacted to multimatrix mesalamine treatment in ways similar to adults, with the ... Read more

February 16, 2016February 16, 2016

Ulcerative Colitis Patients Resistant to Treatment May Find Golimumab a Viable Therapeutic Option

IBD News, News, Ulcerative colitis

Golimumab (symponi) is the latest addition to TNF-α blocking drugs for inflammatory bowel diseases (IBD) such as ulcerative colitis (UC). A summary of all available safety and efficacy data on the ... Read more

February 15, 2016February 15, 2016

Treatment of IBD Moves Forward with Partnership Between Synlogic and AbbVie to Develop New Class of Medicines

Crohn's Disease, IBD News, News, Ulcerative colitis

Synlogic recently announced the establishment of a global Research and Development collaboration with AbbVie to develop innovative medicines for the treatment of inflammatory bowel disease (IBD), taking advantage of Synlogic’s proprietary ... Read more

February 12, 2016February 12, 2016

First Biosimilar Therapy for Crohn’s Disease and Ulcerative Colitis Is Focus of FDA Meeting

Crohn's Disease, IBD News, News, Ulcerative colitis

The U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee recently met to review a biologics license application (BLA) submitted by Celltrion Inc. for its compound CT-P13, a proposed biosimilar to Remicade ... Read more

February 10, 2016February 10, 2016

Ulcerative Colitis Disease Activity: Rectosigmoidoscopy Strongly Correlates With Colonoscopy Results

IBD News, News, Ulcerative colitis

In a new study, researchers compared the efficacy of two techniques, rectosigmoidoscopy and colonoscopy, for the measurement of endoscopic healing in patients with ulcerative colitis, and found a strong correlation ... Read more

February 8, 2016February 8, 2016

Fecal Volatile Metabolites May Constitute Valuable Non-invasive Biomarkers for IBD

Crohn's Disease, News, Ulcerative colitis

New research indicates that the analysis of vapors from patients’ fecal samples is a potential non-invasive tool for an early differential diagnosis of inflammatory bowel diseases (IBD), namely Crohn’s disease ... Read more

February 5, 2016February 5, 2016

Drug for Ulcerative Colitis Is Focus of OASIS Clinical Trial

IBD News, News, Ulcerative colitis

A new study being conducted in more than 100 clinical centers across the world is evaluating the safety and efficacy of a new investigational drug for the treatment of mild ... Read more

February 2, 2016September 26, 2016

Dietary Management of Ulcerative Colitis, Gastroenterological Conditions Aided With New Probiotic

IBD News, News, Ulcerative colitis

ExeGi Pharma, based in Gaithersburg, Maryland, recently announced the launch of Visbiome and Visbiome Extra Strength, the company’s new probiotic formulations for the dietary management of gastroenterological conditions such as ulcerative colitis, ... Read more